Publications

5674 Results

Role of EGFR pathway activation in never smoking patients with lung cancer

Authors
PC Mack
Journal / Conference
Journal of Thoracic Oncology 4(9):suppl 1, abst. M39.3, S164 (oral presentation, 13th World Conference of Lung Cancer)
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0424

S0536: Carboplatin, paclitaxel, cetuximab and bevacizumab followed by cetuximab and bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC), a SWOG phase II study

Authors
ES Kim;RS Herbst;J Moon;M Redman;S Dakhil;F Hirsch;P Mack;W Franklin;K Kelly;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 4(9):suppl 1, abst. #PD3.5.5, S455; IASLC 13th World Conf on Lung Cancer, oral;
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0536

S9900 trial update, mature analysis

Authors
KM Pisters;E Vallieres;P Bunn;J Crowley;K Chansky;D Gandara
Journal / Conference
Journal of Thoracic Oncology 4(9):suppl. 1, Abst. #E9.3, S201; 2009 (IASLC 13th World Conf on Lung Cancer, oral;
Year
2009
Research Committee(s)
Lung
Study Number(s)
S9900

Long-term survival analysis ofthe North American Intergroup study C9011 comparing fludarabine (f) and chlorambucil (c) in previously untreated patients with chronic lymphocytic leukemia (CLL)

Authors
K Rai;BL Peterson;FR Appelbaum;M Tallman;A Belch;VA Morrison;RA Larson
Journal / Conference
Blood 114:abstr #536 (ASH 2009 Annual Meeting, oral presentation)
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

The influence of older age on physician and patient decision-making regarding enrollment to breast cancer clinical trials

Authors
S Javid;J Unger;J Gralow;C Moinpour;A Wozniak;JW Goodwin;P Lara;P Williams;L Hutchins;C Gotay;K Albain
Journal / Conference
San Antonio Breast Cancer Symposium, poster, abst. #3077
Year
2009
Research Committee(s)
Cancer Survivorship
Study Number(s)
S0316

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine/cytarabine for relapsed/refractory acute lymphocytic leukemia

Authors
A Advani;H Gundacker;L Sala-Torra;J Radich;R Lai;J Lancet;S Coutre;RK Stuart;MP Mims;P Stiff;F Appelbaum
Journal / Conference
Blood 114:abst. #3094, 2009 (poster presentation)
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
S0530

Lack of low-risk pathologic findings in SWOG 8794

Authors
G Swanson;B Goldman;C Tangen;IM Thompson;J Chin;E Messing;E Canby-Higano;J Forman;E Crawford
Journal / Conference
International Journal of Radiation Oncology, Biology & Physics 75(S):abst #20, S10, 2009 (oral pres., ASTRO)
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Results of chemotherapy alone, with sequential or concurrent addition of 52 weeks of trastuzumab in the NCCTG N9831 HER2-positive adjuvant breast cancer trial

Authors
E Perez;VJ Suman;NE Davidson;J Gralow;P Kaufman;JN Ingle;SR Dakhil;J Zujewski;TM Pisansky;R Jenkins
Journal / Conference
San Antonio Breast Cancer Symposium abst. #80 (annual meeting, general session)
Year
2009
Research Committee(s)
Breast
Study Number(s)
N9831

Biased hormonal therapy duration analysis makes results uninterpretable [PMID19786655]

Authors
CM Tangen;BH Goldman;GP Swanson;IM Thompson
Journal / Conference
Journal of Clinical Oncology 27(33):e203
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
S9921

Chemoprevention of prostate cancer. PMID: 19524966

Authors
IM Thompson;CM Tangen;P Goodman;MS Lucia;E Klein
Journal / Conference
Journal of Urology 182(2):499-507
Year
2009
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217